Manufacturers Life Insurance Company, The Bio Xcel Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 16, 2022	SELL	$20.12 - $35.09 $194,077 - $338,478	-9,646 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$23.84 - $32.03 $10,704 - $14,381	449 Added 4.88%	9,646 $293,000
Q2 2021 Aug 12, 2021	BUY	$29.06 - $38.83 $49,343 - $65,933	1,698 Added 22.64%	9,197 $267,000
Q1 2021 May 03, 2021	SELL	$39.04 - $64.6 $16,123 - $26,679	-413 Reduced 5.22%	7,499 $324,000
Q4 2020 Feb 12, 2021	BUY	$42.46 - $56.58 $37,194 - $49,564	876 Added 12.45%	7,912 $366,000
Q3 2020 Nov 09, 2020	BUY	$37.44 - $64.63 $17,858 - $30,828	477 Added 7.27%	7,036 $305,000
Q2 2020 Aug 10, 2020	BUY	$17.62 - $58.71 $115,569 - $385,078	6,559 New	6,559 $333,000

3.06M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $83.5M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.